Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Permanent Cell Line Cell, Epithelial Cell, Cell Culture
DISEASE(S): Breast Cancer
SUBMITTER: Toma Tebaldi
LAB HEAD: Gabriella Viero
PROVIDER: PXD009417 | Pride | 2018-11-21
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
MCF7_tot_1.raw | Raw | |||
MCF7_tot_2.raw | Raw | |||
MCF7_tot_3.raw | Raw | |||
MaxQuant_andromeda.zip | Other | |||
MaxQuant_txt.zip | Other |
Items per page: 5 1 - 5 of 5 |
Clamer Massimiliano M Tebaldi Toma T Lauria Fabio F Bernabò Paola P Gómez-Biagi Rodolfo F RF Marchioretto Marta M Kandala Divya T DT Minati Luca L Perenthaler Elena E Gubert Daniele D Pasquardini Laura L Guella Graziano G Groen Ewout J N EJN Gillingwater Thomas H TH Quattrone Alessandro A Viero Gabriella G
Cell reports 20181001 4
Ribosome profiling, or Ribo-seq, is based on large-scale sequencing of RNA fragments protected from nuclease digestion by ribosomes. Thanks to its unique ability to provide positional information about ribosomes flowing along transcripts, this method can be used to shed light on mechanistic aspects of translation. However, current Ribo-seq approaches lack the ability to distinguish between fragments protected by either ribosomes in active translation or inactive ribosomes. To overcome this possi ...[more]